Radiopharmaceuticals for Positron Emission Tomography: Methodological Aspects
Radiochemical methodology constitutes the most important base for the successful functioning of a PET group in the routine production and development of radiopharmaceuticals. Of the several hundred products which have been labelled with positron emitters during the past two decades about 35 are pres...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Dordrecht
Springer Netherlands
1993
|
Schriftenreihe: | Developments in Nuclear Medicine
24 |
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | Radiochemical methodology constitutes the most important base for the successful functioning of a PET group in the routine production and development of radiopharmaceuticals. Of the several hundred products which have been labelled with positron emitters during the past two decades about 35 are presently considered to be of major interest. The time for a state-of-the-art review is right, since this field has advanced over the past fifteen years to reach a level where guidelines can now be suggested. Chapters of this book deal with each of the main methodological aspects of the chemistry needed to develop an effective radiopharmaceutical, namely radionuclide production, automation and metabolite analysis. A further chapter on QA/QC is written by a broadly-based expert group and is meant to provide a guideline and a base for future monographs and regulations on major PET radiopharmaceuticals of today. This book will help the increasing numbers of scientists who are now entering the field of PET to appreciate the methodological aspects that are normally addressed by chemists in relation to PET radiopharmaceuticals; it provides many useful practical guidelines and will promote early success in their own endeavours, since these will often necessarily begin by establishing chemical methodology of the kind discussed here |
Beschreibung: | 1 Online-Ressource (XX, 180 p) |
ISBN: | 9789401582049 |
DOI: | 10.1007/978-94-015-8204-9 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV046144330 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1993 |||| o||u| ||||||eng d | ||
020 | |a 9789401582049 |9 978-94-015-8204-9 | ||
024 | 7 | |a 10.1007/978-94-015-8204-9 |2 doi | |
035 | |a (ZDB-2-SME)978-94-015-8204-9 | ||
035 | |a (OCoLC)1119017698 | ||
035 | |a (DE-599)BVBBV046144330 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.0757 |2 23 | |
084 | |a YR 2500 |0 (DE-625)154094: |2 rvk | ||
245 | 1 | 0 | |a Radiopharmaceuticals for Positron Emission Tomography |b Methodological Aspects |c edited by Gerhard Stöcklin, Victor W. Pike |
264 | 1 | |a Dordrecht |b Springer Netherlands |c 1993 | |
300 | |a 1 Online-Ressource (XX, 180 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Developments in Nuclear Medicine |v 24 | |
520 | |a Radiochemical methodology constitutes the most important base for the successful functioning of a PET group in the routine production and development of radiopharmaceuticals. Of the several hundred products which have been labelled with positron emitters during the past two decades about 35 are presently considered to be of major interest. The time for a state-of-the-art review is right, since this field has advanced over the past fifteen years to reach a level where guidelines can now be suggested. Chapters of this book deal with each of the main methodological aspects of the chemistry needed to develop an effective radiopharmaceutical, namely radionuclide production, automation and metabolite analysis. A further chapter on QA/QC is written by a broadly-based expert group and is meant to provide a guideline and a base for future monographs and regulations on major PET radiopharmaceuticals of today. This book will help the increasing numbers of scientists who are now entering the field of PET to appreciate the methodological aspects that are normally addressed by chemists in relation to PET radiopharmaceuticals; it provides many useful practical guidelines and will promote early success in their own endeavours, since these will often necessarily begin by establishing chemical methodology of the kind discussed here | ||
650 | 4 | |a Imaging / Radiology | |
650 | 4 | |a Diagnostic Radiology | |
650 | 4 | |a Nuclear Medicine | |
650 | 4 | |a Radiology, Medical | |
650 | 4 | |a Nuclear medicine | |
650 | 0 | 7 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Radiopharmakon |0 (DE-588)4048223-6 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |D s |
689 | 0 | 1 | |a Radiopharmakon |0 (DE-588)4048223-6 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Stöcklin, Gerhard |4 edt | |
700 | 1 | |a Pike, Victor W. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789048142859 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792323402 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401582056 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-94-015-8204-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031524515 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-94-015-8204-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180479588433920 |
---|---|
any_adam_object | |
author2 | Stöcklin, Gerhard Pike, Victor W. |
author2_role | edt edt |
author2_variant | g s gs v w p vw vwp |
author_facet | Stöcklin, Gerhard Pike, Victor W. |
building | Verbundindex |
bvnumber | BV046144330 |
classification_rvk | YR 2500 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-94-015-8204-9 (OCoLC)1119017698 (DE-599)BVBBV046144330 |
dewey-full | 616.0757 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.0757 |
dewey-search | 616.0757 |
dewey-sort | 3616.0757 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-94-015-8204-9 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03447nmm a2200553zcb4500</leader><controlfield tag="001">BV046144330</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401582049</subfield><subfield code="9">978-94-015-8204-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-015-8204-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-015-8204-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119017698</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144330</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.0757</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YR 2500</subfield><subfield code="0">(DE-625)154094:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiopharmaceuticals for Positron Emission Tomography</subfield><subfield code="b">Methodological Aspects</subfield><subfield code="c">edited by Gerhard Stöcklin, Victor W. Pike</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XX, 180 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Developments in Nuclear Medicine</subfield><subfield code="v">24</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Radiochemical methodology constitutes the most important base for the successful functioning of a PET group in the routine production and development of radiopharmaceuticals. Of the several hundred products which have been labelled with positron emitters during the past two decades about 35 are presently considered to be of major interest. The time for a state-of-the-art review is right, since this field has advanced over the past fifteen years to reach a level where guidelines can now be suggested. Chapters of this book deal with each of the main methodological aspects of the chemistry needed to develop an effective radiopharmaceutical, namely radionuclide production, automation and metabolite analysis. A further chapter on QA/QC is written by a broadly-based expert group and is meant to provide a guideline and a base for future monographs and regulations on major PET radiopharmaceuticals of today. This book will help the increasing numbers of scientists who are now entering the field of PET to appreciate the methodological aspects that are normally addressed by chemists in relation to PET radiopharmaceuticals; it provides many useful practical guidelines and will promote early success in their own endeavours, since these will often necessarily begin by establishing chemical methodology of the kind discussed here</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Imaging / Radiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnostic Radiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiology, Medical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear medicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Radiopharmakon</subfield><subfield code="0">(DE-588)4048223-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Radiopharmakon</subfield><subfield code="0">(DE-588)4048223-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stöcklin, Gerhard</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pike, Victor W.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789048142859</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792323402</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401582056</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-015-8204-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524515</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-015-8204-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV046144330 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:25Z |
institution | BVB |
isbn | 9789401582049 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524515 |
oclc_num | 1119017698 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XX, 180 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | Springer Netherlands |
record_format | marc |
series2 | Developments in Nuclear Medicine |
spelling | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects edited by Gerhard Stöcklin, Victor W. Pike Dordrecht Springer Netherlands 1993 1 Online-Ressource (XX, 180 p) txt rdacontent c rdamedia cr rdacarrier Developments in Nuclear Medicine 24 Radiochemical methodology constitutes the most important base for the successful functioning of a PET group in the routine production and development of radiopharmaceuticals. Of the several hundred products which have been labelled with positron emitters during the past two decades about 35 are presently considered to be of major interest. The time for a state-of-the-art review is right, since this field has advanced over the past fifteen years to reach a level where guidelines can now be suggested. Chapters of this book deal with each of the main methodological aspects of the chemistry needed to develop an effective radiopharmaceutical, namely radionuclide production, automation and metabolite analysis. A further chapter on QA/QC is written by a broadly-based expert group and is meant to provide a guideline and a base for future monographs and regulations on major PET radiopharmaceuticals of today. This book will help the increasing numbers of scientists who are now entering the field of PET to appreciate the methodological aspects that are normally addressed by chemists in relation to PET radiopharmaceuticals; it provides many useful practical guidelines and will promote early success in their own endeavours, since these will often necessarily begin by establishing chemical methodology of the kind discussed here Imaging / Radiology Diagnostic Radiology Nuclear Medicine Radiology, Medical Nuclear medicine Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd rswk-swf Radiopharmakon (DE-588)4048223-6 gnd rswk-swf Positronen-Emissions-Tomografie (DE-588)4129799-4 s Radiopharmakon (DE-588)4048223-6 s 1\p DE-604 Stöcklin, Gerhard edt Pike, Victor W. edt Erscheint auch als Druck-Ausgabe 9789048142859 Erscheint auch als Druck-Ausgabe 9780792323402 Erscheint auch als Druck-Ausgabe 9789401582056 https://doi.org/10.1007/978-94-015-8204-9 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects Imaging / Radiology Diagnostic Radiology Nuclear Medicine Radiology, Medical Nuclear medicine Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd Radiopharmakon (DE-588)4048223-6 gnd |
subject_GND | (DE-588)4129799-4 (DE-588)4048223-6 |
title | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects |
title_auth | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects |
title_exact_search | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects |
title_full | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects edited by Gerhard Stöcklin, Victor W. Pike |
title_fullStr | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects edited by Gerhard Stöcklin, Victor W. Pike |
title_full_unstemmed | Radiopharmaceuticals for Positron Emission Tomography Methodological Aspects edited by Gerhard Stöcklin, Victor W. Pike |
title_short | Radiopharmaceuticals for Positron Emission Tomography |
title_sort | radiopharmaceuticals for positron emission tomography methodological aspects |
title_sub | Methodological Aspects |
topic | Imaging / Radiology Diagnostic Radiology Nuclear Medicine Radiology, Medical Nuclear medicine Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd Radiopharmakon (DE-588)4048223-6 gnd |
topic_facet | Imaging / Radiology Diagnostic Radiology Nuclear Medicine Radiology, Medical Nuclear medicine Positronen-Emissions-Tomografie Radiopharmakon |
url | https://doi.org/10.1007/978-94-015-8204-9 |
work_keys_str_mv | AT stocklingerhard radiopharmaceuticalsforpositronemissiontomographymethodologicalaspects AT pikevictorw radiopharmaceuticalsforpositronemissiontomographymethodologicalaspects |